Innogest sgr announced yesterday the second closing of Innogest Capital II fund at 70 million euros out of a non declared target of 60-80 millions. Fundraising will be close next February.
New investors contributing to the second closing include the European Investment Fund and some leading industry experts in the firm’s areas of interest, that joined existing private and institutional investors as well as Fondo Nazionale dell’Innovazione.
Founded by Claudio Giuliano, che venture capital firm targets companies in the Ict/digital and medical technologies sectors. Since 2007 the Innogest team invested in 24 companies, 4 of which through its new fund, and helped its portfolio companies in raising over 120 millions in co-investments. Innogest II invested in New Vision, Withfounders, Formabilio and Atricath while the first
The first fund, Innogest Capital, in 2007 raised 80 million euros and since then invested in 20 companies and sold two of them (Silicon Biosystems which has been sold to the Italian pharmaceutical group Menarini, and Singular ID, which was sold back in 2008 to Bilcare SIngapore).
